Literature DB >> 14618078

Local thrombolytic therapy in cancer patients with central venous catheter occlusion in urgent need of antiblastic treatment: a single institution experience.

Alberto Agazzi1, Daniele Laszlo, Franco Orsi, Roberto Biffi, Giovanni Martinelli.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14618078     DOI： 10.1023/b:thro.0000003324.54575.1f

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  12 in total

Review 1.  Thrombotic complications of central venous catheters in cancer patients.

Authors:  M Monreal; E Davant
Journal:  Acta Haematol       Date:  2001       Impact factor: 2.195

2.  Long-term follow-up of upper extremity implanted venous access devices in oncology patients.

Authors:  R D Lyon; K A Griggs; A M Johnson; J R Olsen
Journal:  J Vasc Interv Radiol       Date:  1999-04       Impact factor: 3.464

Review 3.  Upper-extremity deep vein thrombosis.

Authors:  Hylton V Joffe; Samuel Z Goldhaber
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

4.  No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipients.

Authors:  S W Lagro; L F Verdonck; I H Borel Rinkes; A W Dekker
Journal:  Bone Marrow Transplant       Date:  2000-11       Impact factor: 5.483

5.  Peripheral infusion ports for central venous access in patients with gynecologic malignancies.

Authors:  M J Cunningham; M B Collins; D C Kredentser; J H Malfetano
Journal:  Gynecol Oncol       Date:  1996-03       Impact factor: 5.482

6.  Initial experience with Healthport miniMax and other peripheral arm ports in patients with advanced gastrointestinal malignancy.

Authors:  C Lersch; F Eckel; R Sader; M Paschalidis; F Zeilhofer; E Schulte-Frohlinde; W Theiss
Journal:  Oncology       Date:  1999-11       Impact factor: 2.935

7.  Upper extremity deep venous thrombosis in cancer patients with venous access devices--prophylaxis with a low molecular weight heparin (Fragmin).

Authors:  M Monreal; A Alastrue; M Rull; X Mira; J Muxart; R Rosell; A Abad
Journal:  Thromb Haemost       Date:  1996-02       Impact factor: 5.249

8.  Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.

Authors:  Patrick Mismetti; Dominique Mille; Silvy Laporte; Véronique Charlet; Andréa Buchmüller-Cordier; Jean-Philippe Jacquin; Pierre Fournel; Claire Dutrey-Dupagne; Herv Decousus
Journal:  Haematologica       Date:  2003-01       Impact factor: 9.941

9.  Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study.

Authors:  M Monreal; E Lafoz; J Ruiz; R Valls; A Alastrue
Journal:  Chest       Date:  1991-02       Impact factor: 9.410

10.  The relationship between the thrombotic and infectious complications of central venous catheters.

Authors:  I I Raad; M Luna; S A Khalil; J W Costerton; C Lam; G P Bodey
Journal:  JAMA       Date:  1994-04-06       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.